That age group was most likely to take the TRIP drug-combo because of a likelier history of ischemic heart disease, hypertension, diabetes and peripheral artery disease, the study found.

• 当出现疑似缺血性心脏病，高血压，周围动脉病变时那个年龄组最易使用三联疗法。